Home
>
National Drug Code (NDC)
>
PANCRELIPASE
PANCRELIPASE - 39822-0205-1 - (pancrelipase)
Drug Information of PANCRELIPASE
| Product NDC: | 39822-0205 |
| Proprietary Name: | PANCRELIPASE |
| Non Proprietary Name: | pancrelipase |
| Active Ingredient(s): | 27000; 5000; 17000 [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp; pancrelipase |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PANCRELIPASE
| Product NDC: | 39822-0205 |
| Labeler Name: | X-GEN Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022210 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20090922 |
Package Information of PANCRELIPASE
| Package NDC: | 39822-0205-1 |
| Package Description: | 1 BOTTLE in 1 CARTON (39822-0205-1) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
NDC Information of PANCRELIPASE
| NDC Code | 39822-0205-1 |
| Proprietary Name | PANCRELIPASE |
| Package Description | 1 BOTTLE in 1 CARTON (39822-0205-1) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
| Product NDC | 39822-0205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pancrelipase |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090922 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | X-GEN Pharmaceuticals, Inc. |
| Substance Name | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
| Strength Number | 27000; 5000; 17000 |
| Strength Unit | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| Pharmaceutical Classes |
